Regenerative Medicine Firm Cesca Therapeutics Eyeing Major Device Players
This article was originally published in The Gray Sheet
Executive Summary
The new company, forming from the merger of ThermoGenesis and TotipotentRx, aims to use its cell processing systems and cell formulations to recast the way physicians treat various cardiovascular and orthopedic problems. It is in discussions with device firms about potential partnerships.